Showing results (11-20 of 90) with videos related to
Sort By:
Pageof 9
Journal of Interpersonal Violence|February 17, 2018
Disclosure of Sexual Violence Among Girls and Young Women Aged 13 to 24 Years: Results From the Violence Against Children Surveys in Nigeria and MalawiKimberly H Nguyen, Howard Kress, Victor Atuchukwu, et al.Ghana Medical Journal|May 30, 2019
Ghana's HIV epidemic and PEPFAR's contribution towards epidemic controlHammad Ali, Frank Amoyaw, Dan Baden, et al.Antimicrobial Agents and Chemotherapy|November 11, 2009
In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistinAndrea Endimiani, Gopi Patel, Kristine M Hujer, et al.HIV/AIDS (Auckland, N.Z.)|September 2, 2021
Ensuring Optimal Community HIV Testing Services in Nigeria Using an Enhanced Community Case-Finding Package (ECCP), October 2019-March 2020: Acceleration to HIV Epidemic ControlIbrahim Jahun, Emilio Dirlikov, Solomon Odafe, et al.AIDS and Behavior|November 30, 2014
Prevalence of rape and client-initiated gender-based violence among female sex workers: Kampala, Uganda, 2012Amee Schwitters, Mahesh Swaminathan, David Serwadda, et al.African Journal of Laboratory Medicine|December 23, 2020
Infant HIV diagnosis and turn-around time for testing in Malawi, 2015Hammad Ali, Peter Minchella, Geoffrey Chipungu, et al.AIDS (London, England)|October 17, 2022
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurveyJonathan Lawton, Marie-Claude Lavoie, Adebobola Bashorun, et al.JMIR Public Health and Surveillance|October 26, 2022
Key Population Size Estimation to Guide HIV Epidemic Responses in Nigeria: Bayesian Analysis of 3-Source Capture-Recapture DataAnne F McIntyre, Andrew Mitchell, Kristen A Stafford, et al.Ejhaem|February 23, 2023
Efficacy analysis of different FLT3 inhibitors in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromeMahesh Swaminathan, Mai M Aly, Abdul Moiz Khan, et al.Blood Advances|March 25, 2026
NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapyAlexandre Bazinet, Alessandra Ferrajoli, Nitin Jain, et al.Pageof 9